You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19

Citation Tools

Article menu
Infectious diseases
Protocol
ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
McCafferty K, Hollowood Z, Allan M, et al
ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19
BMJ Open 2021;11:e049650. doi: 10.1136/bmjopen-2021-049650